@zerohedge Assuming NVDA beats on EPS and Sales the only thing that matters is guidance which should be stratospheric due to rising prices. I do not hold any NVDA security whatsoever.
@zerohedge That is Goldman wanting to position themselves on the contrarian side of the trade. NVDA likely beats Sales & EPS and likely guides up since they are raising prices.
NVDA highly likely to beat on earnings & sales. The important part of today's report is guidance, which should be phenomenal given the fact that they have advised their customers of a price increase for their products accross the board. It will likely lead to margin expansion.
NVDA, TSM and MU green... Just watch tomorrow these stocks begin their next leg up. If you want to buy tomorrow as it clears today's highs will be your opportunity to buy. Deal with Iran announcement will bring the US 10Y treasury below 4.60%
Just wait, at the 11th hour Trump will announce that they have a deal with Iran and all of the AI stocks will rip. Just like what he just pulled with Canada.
NVDA and MU are about to turn green. Huge reversal recovery. This is the type of shakeout where HFs take your money by creating a good size selloff and getting the "weak hands" to sell into weakness.
Ready? HFs are dumping the positions they bought at the bottom and getting ready to go short again... Watch as the QQQ just cannot bet up to green. Watch as the high flying stocks got close to even then sold off a bit again.
Vey crazy market reversal in QQQ. MU, SNDK, NVT, GLW, TSM, ASML. This is the hedge funds shorting and then covering. Trying to get retail to sell so they can profit on the way down and on the wy back up. Watch them try it a couple more times today.
@zerohedge Let go of the former leaders and find the new ones. Momentum is shifting. The former leaders need to go through consolidation. The new leaders will lead. Momentum isn't dying. It is shifting. Follow the money flow.
Stocks rarely trade on fundamentals. Look at PLTR. The last 3 earnings have been the best in history and yet the stock continues to struggle after a significant selloff. Stocks move due to fund flows. When should you buy a stock? Only in a Stage 2 uptrend.
Biotech is one of the leading categories for high performing stocks. Look for innovation, earnings and cashflow. In a difficult market you have to move away from the promise at times and find the companies that have accelerated their sales and earnings.
Software is gaining traction, but you have to find the leaders that are in in an uptrend completing their consolidation pattern. Might this be one of them?
Find the leaders and stick with them. NVDA, SNDK, MU and a lot of the recent leaders now need to go through some form of consolidation to become new leaders. Rotate to where the new leaders are.